|
|
Volumn 7, Issue 6, 1998, Pages 905-928
|
|
Prospects for bioreductive drug development
|
|
Author keywords
AQ4N; Bioreductive drugs; Blood flow; DT diaphorase; Enzymology; EO9; GDEPT; Hypoxia markers; Mitomycin C; Nitroimidazoles; RSU 1069; Tirapazamine
|
|
Indexed keywords
1 AZIRIDINO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL;
1,4 BIS[[2 (DIMETHYLAMINO N OXIDE)ETHYL]AMINO] 5,8 DIHYDROXYANTHRAQUINONE;
ANTINEOPLASTIC AGENT;
AZIRIDINYLBENZOQUINONE DERIVATIVE;
CYTOCHROME P450 REDUCTASE;
E 09;
MITOMYCIN C;
NITRIC OXIDE SYNTHASE;
NITROIMIDAZOLE;
NITROIMIDAZOLE DERIVATIVE;
PRODRUG;
TIRAPAZAMINE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
BIOCHEMISTRY;
CANCER;
CYTOTOXICITY;
DRUG ACTIVITY;
DRUG DELIVERY SYSTEM;
DRUG DEVELOPMENT;
HUMAN;
HYPOXIA;
HYPOXIC CELL;
PHOTODYNAMIC THERAPY;
PROMOTER REGION;
REVIEW;
STRUCTURE ACTIVITY RELATION;
|
|
EID: 0031864029
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.7.6.905 Document Type: Review |
|
Times cited : (11)
|
|
References (239)
|
